Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion

Standard

Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion. / Scheldeman, Lauranne; Wouters, Anke; Dupont, Patrick; Christensen, Soren; Boutitie, Florent; Cheng, Bastian; Ebinger, Martin; Endres, Matthias; Fiebach, Jochen B; Gerloff, Christian; Muir, Keith W; Nighoghossian, Norbert; Pedraza, Salvador; Simonsen, Claus Z; Ringelstein, Erich B; Chamorro, Angel; Grond, Martin; Laage, Rico; Schneider, Armin; Thomalla, Götz; Thijs, Vincent; Lemmens, Robin.

in: STROKE, Jahrgang 52, Nr. 7, 07.2021, S. 2338-2346.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Scheldeman, L, Wouters, A, Dupont, P, Christensen, S, Boutitie, F, Cheng, B, Ebinger, M, Endres, M, Fiebach, JB, Gerloff, C, Muir, KW, Nighoghossian, N, Pedraza, S, Simonsen, CZ, Ringelstein, EB, Chamorro, A, Grond, M, Laage, R, Schneider, A, Thomalla, G, Thijs, V & Lemmens, R 2021, 'Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion', STROKE, Jg. 52, Nr. 7, S. 2338-2346. https://doi.org/10.1161/STROKEAHA.120.033071

APA

Scheldeman, L., Wouters, A., Dupont, P., Christensen, S., Boutitie, F., Cheng, B., Ebinger, M., Endres, M., Fiebach, J. B., Gerloff, C., Muir, K. W., Nighoghossian, N., Pedraza, S., Simonsen, C. Z., Ringelstein, E. B., Chamorro, A., Grond, M., Laage, R., Schneider, A., ... Lemmens, R. (2021). Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion. STROKE, 52(7), 2338-2346. https://doi.org/10.1161/STROKEAHA.120.033071

Vancouver

Scheldeman L, Wouters A, Dupont P, Christensen S, Boutitie F, Cheng B et al. Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion. STROKE. 2021 Jul;52(7):2338-2346. https://doi.org/10.1161/STROKEAHA.120.033071

Bibtex

@article{9fca89a9957e4df59faa8f766ba654f8,
title = "Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion",
abstract = "Background and Purpose: We aimed to investigate fluid-attenuated inversion recovery changes in the penumbra.Methods: We determined core and perfusion lesions in subjects from the WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke) and AXIS 2 trial (Granulocyte Colony-Stimulating Factor in Patients With Acute Ischemic Stroke) with perfusion- and diffusion-weighted imaging at baseline. Only subjects with a mismatch volume >15 mL and ratio >1.2 were included. We created voxel-based relative fluid-attenuated inversion recovery signal intensity (rFLAIR SI) maps at baseline and follow-up. We studied rFLAIR SI in 2 regions of interest: baseline penumbra (baseline perfusion lesion−[core lesion+voxels with apparent diffusion coefficient <620 10−6 mm2/s]) and noninfarcted penumbra (baseline perfusion lesion−follow-up fluid-attenuated inversion recovery lesion) at 24 hours (WAKE-UP) or 30 days (AXIS 2). We analyzed the association between rFLAIR SI and severity of hypoperfusion, defined as time to maximum of the residue function.Results: In the baseline penumbra, rFLAIR SI was elevated (ratio, 1.04; P=1.7×10−13; n=126) and correlated with severity of hypoperfusion (Pearson r, 0.03; P<1.0×10−4; n=126). In WAKE-UP, imaging at 24 hours revealed a further increase of rFLAIR SI in the noninfarcted penumbra (ratio, 1.05 at 24 hours versus 1.03 at baseline; P=7.1×10−3; n=43). In AXIS 2, imaging at 30 days identified reversibility of the rFLAIR SI (ratio, 1.02 at 30 days versus 1.04 at baseline; P=1.5×10−3; n=26) since it was no longer different from 1 (ratio, 1.01 at 30 days; P=0.099; n=26).Conclusions: Penumbral rFLAIR SI increases appear early after stroke onset, correlate with severity of hypoperfusion, further increase at 24 hours, and are reversible by 30 days.Registration: URL: https://clinicaltrials.gov; Unique identifier: NCT01525290. URL: https://clinicaltrials.gov; Unique identifier: NCT00927836.",
author = "Lauranne Scheldeman and Anke Wouters and Patrick Dupont and Soren Christensen and Florent Boutitie and Bastian Cheng and Martin Ebinger and Matthias Endres and Fiebach, {Jochen B} and Christian Gerloff and Muir, {Keith W} and Norbert Nighoghossian and Salvador Pedraza and Simonsen, {Claus Z} and Ringelstein, {Erich B} and Angel Chamorro and Martin Grond and Rico Laage and Armin Schneider and G{\"o}tz Thomalla and Vincent Thijs and Robin Lemmens",
year = "2021",
month = jul,
doi = "10.1161/STROKEAHA.120.033071",
language = "English",
volume = "52",
pages = "2338--2346",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

RIS

TY - JOUR

T1 - Reversible Edema in the Penumbra Correlates With Severity of Hypoperfusion

AU - Scheldeman, Lauranne

AU - Wouters, Anke

AU - Dupont, Patrick

AU - Christensen, Soren

AU - Boutitie, Florent

AU - Cheng, Bastian

AU - Ebinger, Martin

AU - Endres, Matthias

AU - Fiebach, Jochen B

AU - Gerloff, Christian

AU - Muir, Keith W

AU - Nighoghossian, Norbert

AU - Pedraza, Salvador

AU - Simonsen, Claus Z

AU - Ringelstein, Erich B

AU - Chamorro, Angel

AU - Grond, Martin

AU - Laage, Rico

AU - Schneider, Armin

AU - Thomalla, Götz

AU - Thijs, Vincent

AU - Lemmens, Robin

PY - 2021/7

Y1 - 2021/7

N2 - Background and Purpose: We aimed to investigate fluid-attenuated inversion recovery changes in the penumbra.Methods: We determined core and perfusion lesions in subjects from the WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke) and AXIS 2 trial (Granulocyte Colony-Stimulating Factor in Patients With Acute Ischemic Stroke) with perfusion- and diffusion-weighted imaging at baseline. Only subjects with a mismatch volume >15 mL and ratio >1.2 were included. We created voxel-based relative fluid-attenuated inversion recovery signal intensity (rFLAIR SI) maps at baseline and follow-up. We studied rFLAIR SI in 2 regions of interest: baseline penumbra (baseline perfusion lesion−[core lesion+voxels with apparent diffusion coefficient <620 10−6 mm2/s]) and noninfarcted penumbra (baseline perfusion lesion−follow-up fluid-attenuated inversion recovery lesion) at 24 hours (WAKE-UP) or 30 days (AXIS 2). We analyzed the association between rFLAIR SI and severity of hypoperfusion, defined as time to maximum of the residue function.Results: In the baseline penumbra, rFLAIR SI was elevated (ratio, 1.04; P=1.7×10−13; n=126) and correlated with severity of hypoperfusion (Pearson r, 0.03; P<1.0×10−4; n=126). In WAKE-UP, imaging at 24 hours revealed a further increase of rFLAIR SI in the noninfarcted penumbra (ratio, 1.05 at 24 hours versus 1.03 at baseline; P=7.1×10−3; n=43). In AXIS 2, imaging at 30 days identified reversibility of the rFLAIR SI (ratio, 1.02 at 30 days versus 1.04 at baseline; P=1.5×10−3; n=26) since it was no longer different from 1 (ratio, 1.01 at 30 days; P=0.099; n=26).Conclusions: Penumbral rFLAIR SI increases appear early after stroke onset, correlate with severity of hypoperfusion, further increase at 24 hours, and are reversible by 30 days.Registration: URL: https://clinicaltrials.gov; Unique identifier: NCT01525290. URL: https://clinicaltrials.gov; Unique identifier: NCT00927836.

AB - Background and Purpose: We aimed to investigate fluid-attenuated inversion recovery changes in the penumbra.Methods: We determined core and perfusion lesions in subjects from the WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke) and AXIS 2 trial (Granulocyte Colony-Stimulating Factor in Patients With Acute Ischemic Stroke) with perfusion- and diffusion-weighted imaging at baseline. Only subjects with a mismatch volume >15 mL and ratio >1.2 were included. We created voxel-based relative fluid-attenuated inversion recovery signal intensity (rFLAIR SI) maps at baseline and follow-up. We studied rFLAIR SI in 2 regions of interest: baseline penumbra (baseline perfusion lesion−[core lesion+voxels with apparent diffusion coefficient <620 10−6 mm2/s]) and noninfarcted penumbra (baseline perfusion lesion−follow-up fluid-attenuated inversion recovery lesion) at 24 hours (WAKE-UP) or 30 days (AXIS 2). We analyzed the association between rFLAIR SI and severity of hypoperfusion, defined as time to maximum of the residue function.Results: In the baseline penumbra, rFLAIR SI was elevated (ratio, 1.04; P=1.7×10−13; n=126) and correlated with severity of hypoperfusion (Pearson r, 0.03; P<1.0×10−4; n=126). In WAKE-UP, imaging at 24 hours revealed a further increase of rFLAIR SI in the noninfarcted penumbra (ratio, 1.05 at 24 hours versus 1.03 at baseline; P=7.1×10−3; n=43). In AXIS 2, imaging at 30 days identified reversibility of the rFLAIR SI (ratio, 1.02 at 30 days versus 1.04 at baseline; P=1.5×10−3; n=26) since it was no longer different from 1 (ratio, 1.01 at 30 days; P=0.099; n=26).Conclusions: Penumbral rFLAIR SI increases appear early after stroke onset, correlate with severity of hypoperfusion, further increase at 24 hours, and are reversible by 30 days.Registration: URL: https://clinicaltrials.gov; Unique identifier: NCT01525290. URL: https://clinicaltrials.gov; Unique identifier: NCT00927836.

U2 - 10.1161/STROKEAHA.120.033071

DO - 10.1161/STROKEAHA.120.033071

M3 - SCORING: Journal article

C2 - 33980046

VL - 52

SP - 2338

EP - 2346

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 7

ER -